Party with a Purpose to Raise Funds for the AACR
For the second consecutive year, the American Association for Cancer Research (AACR) has been designated the beneficiary of Party...
Tag: Ovarian cancer
For the second consecutive year, the American Association for Cancer Research (AACR) has been designated the beneficiary of Party...
On Sunday, almost 300 of the greatest minds in ovarian cancer research will come together in Pittsburgh to discuss...
Earlier this week, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic niraparib (Zejula) for the...
On Monday, the U.S. Food and Drug Administration (FDA) announced good news for a subgroup of patients with ovarian...
New imaging system can help surgeons get more cancer out; Presurgery chemo can make ovarian cancer responsive to immunotherapy...
The past year brought some progress, which the American Association for Cancer Research highlighted in a guest article for...
Guest Post by Roswell Park Cancer Institute Department of Public Affairs
Guest Post by Alan D. D’Andrea, MD, and Elizabeth M. Swisher, MD SU2C-OCRF-OCNA-NOCC Dream Team
Laura Shawver, PhD, is working to change the game for ovarian cancer.
In my first post in this series highlighting some of the studies presented at the AACR Annual Meeting 2015...